This review will document what is known about the science and impacts of Long COVID, the lessons that should have been drawn from previous post-viral illnesses and the refusal of world capitalism to address this massive and ongoing social catastrophe.
RECOVERY results do not support aspirin use in this setting Treatment with aspirin did not bring about any clinically meaningful improvements in outcomes among patients hospitalized with Covid-19 in the large, randomized, open-label RECOVERY trial. Aspirin was not associated with reductions in 28-day mortality or in the risk of progression to invasive mechanical ventilation in
In its Eighth Year, the Global Campaign Aims to Increase Public Awareness of Blood Clots that Result from Hospitalization and COVID-19 CHAPEL HILL, N.C., Oct. 13, 2021 /PRNewswire/